EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review)

Junxin Li, Yanyu Li, Lin Fu, Huiling Chen, Fei Du, Zhongshu Wang, Yan Zhang, Yu Huang, Jidong Miao, Yi Xiao

International Journal of Oncology · 19.03.2025 · 66 (5) · 1-29

DOI: 10.3892/ijo.2025.5741 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 19.03.2025. Verfasst von Junxin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zigong Fourth People's Hospital, Zigong, Sichuan 643000, P.R. China. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Neoplasm, RNA, Untranslated, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 275 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of resistance to antitumor drugs in cancer cells presents a notable obstacle in cancer therapy. Metabolic reprogramming is characterized by enhanced glycolysis, disrupted lipid metabolism, glutamine dependence and mitochondrial dysfunction. In addition to promoting tumor growth and metastasis, metabolic reprogramming mediates drug resistance through diverse molecular mechanisms, offering novel opportunities for therapeutic intervention. Non‑coding RNAs (ncRNAs), a diverse class of RNA molecules that lack protein‑coding function, represent a notable fraction of the human genome. Due to their distinct expression profiles and multifaceted roles in various cancers, ncRNAs have relevance in cancer pathophysiology. ncRNAs orchestrate metabolic abnormalities associated with drug resistance in cancer cells. The present review provides a comprehensive analysis of the mechanisms by which metabolic reprogramming drives drug resistance, with an emphasis on the regulatory roles of ncRNAs in glycolysis, lipid metabolism, mitochondrial dysfunction and glutamine metabolism. Furthermore, the present review aimed to discuss the potential of ncRNAs as biomarkers for predicting chemotherapy responses, as well as emerging strategies to target ncRNAs that modulate metabolism, particularly in the context of combination therapy with anti‑cancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDrug Resistance, NeoplasmRNA, UntranslatedAntineoplastic AgentsHumansLipid MetabolismGene Expression Regulation, NeoplasticGlutamineMitochondriaAnimalsGlycolysisBiomarkers, TumorMetabolic Reprogramming

Stichwörter der Autor:innen

drug‑resistantferroptosisglutamineglycolysislipid metabolismmitochondrionnon‑coding RNA

Substanzen

RNA, UntranslatedAntineoplastic AgentsGlutamineBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pharmacy, Zigong Fourth People's Hospital, Zigong, Sichuan 643000, P.R. China.
  • Department of Pharmacy, The Fourth Affiliated Hospital of Southwest Medical University, Meishan, Sichuan 64200, P.R. China.
  • Department of Oncology, Zigong Fourth People's Hospital, Zigong, Sichuan 643000, P.R. China.

Zitieren

APA

Li, J., Li, Y., Fu, L., Chen, H., Du, F., Wang, Z., Zhang, Y., Huang, Y., Miao, J., & Xiao, Y. (2025). Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review). International Journal of Oncology, 66(5), 1-29. https://doi.org/10.3892/ijo.2025.5741

Vancouver

Li J, Li Y, Fu L, Chen H, Du F, Wang Z, et al. Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review). International Journal of Oncology. 2025;66(5):1-29. doi:10.3892/ijo.2025.5741

BibTeX
@article{Li2025,
  author = {Li, Junxin and Li, Yanyu and Fu, Lin and Chen, Huiling and Du, Fei and Wang, Zhongshu and Zhang, Yan and Huang, Yu and Miao, Jidong and Xiao, Yi},
  title = {Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  volume = {66},
  number = {5},
  pages = {1--29},
  doi = {10.3892/ijo.2025.5741}
}
Kostenlos starten →